These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9361377

  • 1. Inhibition of collagen-induced platelet aggregation by argatroban in patients with acute cerebral infarction.
    Imiya M, Matsuo T.
    Thromb Res; 1997 Oct 15; 88(2):245-50. PubMed ID: 9361377
    [Abstract] [Full Text] [Related]

  • 2. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC, Jiang X.
    Thromb Haemost; 2010 Aug 15; 104(2):302-10. PubMed ID: 20589316
    [Abstract] [Full Text] [Related]

  • 3. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.
    Lunven C, Gauffeny C, Lecoffre C, O'Brien DP, Roome NO, Berry CN.
    Thromb Haemost; 1996 Jan 15; 75(1):154-60. PubMed ID: 8713795
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of factor Xa-induced platelet aggregation by a selective thrombin inhibitor, argatroban.
    Kawai H, Yamamoto T, Hara H, Tamao Y.
    Thromb Res; 1994 May 01; 74(3):185-91. PubMed ID: 8042187
    [Abstract] [Full Text] [Related]

  • 5. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E, Lunven C, Gauffeny C, Roome NO, Berry CN.
    Thromb Haemost; 1998 Nov 01; 80(5):840-4. PubMed ID: 9843181
    [Abstract] [Full Text] [Related]

  • 6. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
    Kato Y, Kita Y, Nishio M, Hirasawa Y, Ito K, Yamanaka T, Motoyama Y, Seki J.
    Eur J Pharmacol; 1999 Nov 19; 384(2-3):197-202. PubMed ID: 10611442
    [Abstract] [Full Text] [Related]

  • 7. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 8. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC, Huang SW, Hwang TL, Kuo SC, Lee FY, Teng CM.
    Br J Pharmacol; 2000 Jul 15; 130(6):1289-96. PubMed ID: 10903968
    [Abstract] [Full Text] [Related]

  • 9. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S.
    Blood Coagul Fibrinolysis; 2008 Sep 15; 19(6):557-67. PubMed ID: 18685439
    [Abstract] [Full Text] [Related]

  • 10. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.
    Li N, He S, Blombäck M, Hjemdahl P.
    Arterioscler Thromb Vasc Biol; 2007 Feb 15; 27(2):407-13. PubMed ID: 17138937
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF.
    Thromb Haemost; 1976 Feb 29; 35(1):151-66. PubMed ID: 785686
    [Abstract] [Full Text] [Related]

  • 12. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M.
    Acta Pol Pharm; 2009 Feb 29; 66(3):235-42. PubMed ID: 19645323
    [Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide-Induced Hemolysis Is Abolished by Inhibition of Thrombin Generation but Not Inhibition of Platelet Aggregation.
    Brauckmann S, Effenberger-Neidnicht K, Nagel M, Mayer C, Peters J, Hartmann M.
    Inflammation; 2019 Oct 29; 42(5):1767-1776. PubMed ID: 31175488
    [Abstract] [Full Text] [Related]

  • 14. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
    Werner MH, Senzel L, Bielawska A, Khan W, Hannun YA.
    Mol Pharmacol; 1991 Apr 29; 39(4):547-56. PubMed ID: 2017154
    [Abstract] [Full Text] [Related]

  • 15. The influence of pH on aggregation of human washed platelets induced by thrombin or collagen.
    Spurej E, Sneddon JM, Vane JR.
    Blood Coagul Fibrinolysis; 1990 Apr 29; 1(1):47-53. PubMed ID: 2102788
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH, Kuo JR, Lu WJ, Chung CL, Chou DS, Huang SY, Lee HC, Sheu JR.
    Biochem Pharmacol; 2013 May 15; 85(10):1478-85. PubMed ID: 23473801
    [Abstract] [Full Text] [Related]

  • 18. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T, Itaya S, Wada H, Ishizawa M, Kimura M, Kajita K, Kanoh Y, Miura A, Muto N, Yasuda K.
    Diabetes; 1998 Sep 15; 47(9):1494-500. PubMed ID: 9726240
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of phospholipase D in human platelets by collagen and thrombin and its relationship to platelet aggregation.
    Chiang TM.
    Biochim Biophys Acta; 1994 Oct 20; 1224(1):147-55. PubMed ID: 7948037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.